Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
Business Insider7d
Merck Stock Loses 9% on Vaccine Shipment Halt to China
Merck & Co. (MRK) stock lost over 9% yesterday on announcing a temporary shipment halt of its Gardasil vaccine to China ... Plus, the shipping pause could bring down Gardasil’s inventory ...
Morningstar7d
Merck's struggles with HPV vaccine send stock to worst selloff in almost 17 years
Merck issued guidance for 2025 that lags consensus ... after the drug company's softer-than-expected guidance amid struggles for its HPV vaccine in China overshadowed a quarterly earnings beat.
Becker's Hospital Review7d
Merck's 2025 outlook falls on cancer vaccine China shipment pause
Gardasil, a vaccine that prevents cancers caused by human papillomavirus has faced declining sales in China, a key market for the product. Merck's shipping pause aims to reduce excess inventory ...
MarketWatch8d
Merck’s struggles with HPV vaccine send stock to worst selloff in almost 17 years
Merck’s stock tumbled 11.8% Tuesday ... after the drug company’s softer-than-expected guidance amid struggles for its HPV vaccine in China overshadowed a quarterly earnings beat.